Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Claude Reubi

Showing results (81-90 of 185) with videos related to

Pageof 19
Sort By:
Molecular and Cellular Endocrinology|November 2, 2011
Characterization of a novel five-transmembrane domain cholecystokinin-2 receptor splice variant identified in human tumorsClaire Sanchez, Chantal Escrieut, Pascal Clerc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomographyMargret Schottelius, Thorsten Poethko, Michael Herz, et al.
Journal of Medicinal Chemistry|July 21, 2006
Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMRChristy Rani R Grace, Judit Erchegyi, Steven C Koerber, et al.
Journal of Medicinal Chemistry|December 12, 2003
Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMRChristy Rani R Grace, Steven C Koerber, Judit Erchegyi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 31, 2007
DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumoursHanwen Zhang, Jochen Schuhmacher, Beatrice Waser, et al.
Journal of Medicinal Chemistry|July 21, 2006
Toward stable N4-modified neurotensins for NTS1-receptor-targeted tumor imaging with 99mTcBerthold A Nock, Anastasia Nikolopoulou, Jean-Claude Reubi, et al.
Endocrinology|November 18, 2003
Distribution of the VPAC2 receptor in peripheral tissues of the mouseAnthony J Harmar, W John Sheward, Christine F Morrison, et al.
Cancer Research|September 18, 2004
Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumorsHanwen Zhang, Jianhua Chen, Christian Waldherr, et al.
Journal of Medicinal Chemistry|January 7, 2005
Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical studyBerthold A Nock, Anastasia Nikolopoulou, Athanassios Galanis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugsTheodosia Maina, Berthold A Nock, Hanwen Zhang, et al.
Pageof 19

Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
Molecular and Cellular Endocrinology|November 2, 2011
Characterization of a novel five-transmembrane domain cholecystokinin-2 receptor splice variant identified in human tumorsClaire Sanchez, Chantal Escrieut, Pascal Clerc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomographyMargret Schottelius, Thorsten Poethko, Michael Herz, et al.
Journal of Medicinal Chemistry|July 21, 2006
Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMRChristy Rani R Grace, Judit Erchegyi, Steven C Koerber, et al.
Journal of Medicinal Chemistry|December 12, 2003
Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMRChristy Rani R Grace, Steven C Koerber, Judit Erchegyi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 31, 2007
DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumoursHanwen Zhang, Jochen Schuhmacher, Beatrice Waser, et al.
Journal of Medicinal Chemistry|July 21, 2006
Toward stable N4-modified neurotensins for NTS1-receptor-targeted tumor imaging with 99mTcBerthold A Nock, Anastasia Nikolopoulou, Jean-Claude Reubi, et al.
Endocrinology|November 18, 2003
Distribution of the VPAC2 receptor in peripheral tissues of the mouseAnthony J Harmar, W John Sheward, Christine F Morrison, et al.
Cancer Research|September 18, 2004
Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumorsHanwen Zhang, Jianhua Chen, Christian Waldherr, et al.
Journal of Medicinal Chemistry|January 7, 2005
Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical studyBerthold A Nock, Anastasia Nikolopoulou, Athanassios Galanis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugsTheodosia Maina, Berthold A Nock, Hanwen Zhang, et al.
Pageof 19